Acyldepsipeptide Analogues: A Future Generation Antibiotics for Tuberculosis Treatment
Open Access
- 15 September 2022
- journal article
- review article
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (9) , 1956
Abstract
Acyldepsipeptides (ADEPs) are a new class of emerging antimicrobial peptides (AMPs), which are currently explored for treatment of pathogenic infections, including tuberculosis (TB). These cyclic hydrophobic peptides have a unique bacterial target to the conventional anti-TB drugs, and present a therapeutic window to overcome Mycobacterium Tuberculosis (M. tb) drug resistance. ADEPs exerts their antibacterial activity on M. tb strains through activation of the protein homeostatic regulatory protease, the caseinolytic protease (ClpP1P2). ClpP1P2 is normally regulated and activated by the ClpP-ATPases to degrade misfolded and toxic peptides and/or short proteins. ADEPs bind and dysregulate all the homeostatic capabilities of ClpP1P2 while inducing non-selective proteolysis. The uncontrolled proteolysis leads to M. tb cell death within the host. ADEPs analogues that have been tested possess cytotoxicity and poor pharmacokinetic and pharmacodynamic properties. However, these can be improved by drug design techniques. Moreover, the use of nanomaterial in conjunction with ADEPs would yield effective synergistic effect. This new mode of action has potential to combat and eradicate the extensive multi-drug resistance (MDR) problem that is currently faced by the public health pertaining bacterial infections, especially TB.Keywords
Funding Information
- Mintek Science Vote (ADR 42304)
This publication has 204 references indexed in Scilit:
- Mycobacterium tuberculosis ClpP Proteases Are Co-transcribed but Exhibit Different Substrate SpecificitiesPLOS ONE, 2013
- The active ClpP protease from M. tuberculosis is a complex composed of a heptameric ClpP1 and a ClpP2 ringThe EMBO Journal, 2012
- Rational Approaches to Improving Selectivity in Drug DesignJournal of Medicinal Chemistry, 2012
- HSA Coated Iron Oxide Nanoparticles as Drug Delivery Vehicles for Cancer TherapyMolecular Pharmaceutics, 2011
- Bioactivation of antituberculosis thioamide and thiourea prodrugs by bacterial and mammalian flavin monooxygenasesChemico-Biological Interactions, 2011
- Acyldepsipeptide Antibiotics Induce the Formation of a Structured Axial Channel in ClpP: A Model for the ClpX/ClpA-Bound State of ClpPChemistry & Biology, 2010
- MultipleN-Methylation of MT-II Backbone Amide Bonds Leads to Melanocortin Receptor Subtype hMC1R Selectivity: Pharmacological and Conformational StudiesJournal of the American Chemical Society, 2010
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Broad-Spectrum Antimicrobial Peptides by Rational Combinatorial Design and High-Throughput Screening: The Importance of Interfacial ActivityJournal of the American Chemical Society, 2009
- Roles of Arginine and Lysine Residues in the Translocation of a Cell-Penetrating Peptide from13C,31P, and19F Solid-State NMRBiochemistry, 2009